M-alpha
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 8 PDB declaration: octameric(8) Consistent with protein copy count | Chain A; UniProt 149–182 Chain B; UniProt 149–182 Chain C; UniProt 149–182 Chain D; UniProt 149–182 Chain E; UniProt 149–182 Chain F; UniProt 149–182 Chain G; UniProt 149–182 Chain H; UniProt 149–182 | Not recorded | No other associated polymer | ELECTRON MICROSCOPY cryo-EM buffer:pH 4.4 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 1.79 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 9JSV | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1TVB Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2 Deposited 2004-06-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded | GOL GLYCEROL × 9 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.216 |
| 1TVB Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2 Deposited 2004-06-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain F
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded | GOL GLYCEROL × 13 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.216 |
| 1TVH Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2 Deposited 2004-06-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded | GOL GLYCEROL × 13 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.247 |
| 1TVH Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2 Deposited 2004-06-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain F
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded | GOL GLYCEROL × 15 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.247 |
| 3CC5 H-2Db complex with human gp100 Deposited 2008-02-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
25–33(9 aa)
Fragment:Extracellular part, UNP residues 25-33
|
Not recorded | SO4 SULFATE ION × 2 GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;10% PEG 6000, 0.1M Ammonium sulfate, 0.1M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.91 Å R-free 0.268 |
| 3CC5 H-2Db complex with human gp100 Deposited 2008-02-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain F
25–33(9 aa)
Fragment:Extracellular part, UNP residues 25-33
|
Not recorded | SO4 SULFATE ION × 1 GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;10% PEG 6000, 0.1M Ammonium sulfate, 0.1M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.91 Å R-free 0.268 |
| 4IS6 Crystal structure of HLA-DR4 bound to GP100 peptide Deposited 2013-01-16 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
44–59(16 aa)
Fragment:UNP residues 44-59
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;PEG8000, magnesium chloride, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å R-free 0.298 |
| 6VM7 SILv44 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV) Deposited 2020-01-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Not recorded | GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;16% v/v PEG3350, 280 mM ammonium citrate dibasic
|
Resolution 2.41 Å R-free 0.241 |
| 6VM8 SILv44 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV) Deposited 2020-01-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Mutation:T210M | FLC CITRATE ANION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;20% v/v PEG3350, 236 mM ammonium citrate dibasic
|
Resolution 2.41 Å R-free 0.221 |
| 6VM9 T4H2 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV) Deposited 2020-01-27 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Mutation:T210M | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;18% v/v PEG10000, 16% v/v glycerol, 250 mM Tris pH 8.5, 60 mM sodium chloride, seeded with crushed crystals
|
Resolution 2.90 Å R-free 0.250 |
| 6VMA T4H2 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV) Deposited 2020-01-27 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;18% v/v PEG10000, 16% v/v glycerol, 100 mM Tris pH 8.5, 100 mM sodium chloride
|
Resolution 2.75 Å R-free 0.219 |
| 6VMC T4H2 T cell receptor bound to HLA-A2 presenting gp100T2L peptide (ILDQVPFSV) Deposited 2020-01-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Mutation:T210L | GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;18% v/v PEG10000, 16% v/v glycerol, 250 mM Tris pH 8.5, 60 mM sodium chloride
|
Resolution 2.85 Å R-free 0.238 |
| 7PHR Structure of a fully assembled T-cell receptor engaging a tumor-associated peptide-MHC I Deposited 2021-08-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 11 PDB declaration: undecameric |
Chain P
280–288(9 aa)
|
Mutation:A9V | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.08 Å |
| 9JST Wild-type native PMEL amyloid - polymorph 1 Deposited 2024-10-01 | Different construct | Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
148–182(35 aa)
Chain B
148–182(35 aa)
Chain C
148–182(35 aa)
Chain D
148–182(35 aa)
Chain E
148–182(35 aa)
Chain F
148–182(35 aa)
Chain G
148–182(35 aa)
Chain H
148–182(35 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å |
| 9JSU Wild-type native PMEL amyloid - polymorph 2 Deposited 2024-10-01 | Different construct | Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
151–183(33 aa)
Chain B
151–183(33 aa)
Chain C
151–183(33 aa)
Chain D
151–183(33 aa)
Chain E
151–183(33 aa)
Chain F
151–183(33 aa)
Chain G
151–183(33 aa)
Chain H
151–183(33 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å |
| 9JSW Wild-type PMEL CAF amyloid -in vitro polymerized Deposited 2024-10-01 | Different construct Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
148–182(35 aa)
Chain B
148–182(35 aa)
Chain C
148–182(35 aa)
Chain D
148–182(35 aa)
Chain E
148–182(35 aa)
Chain F
148–182(35 aa)
Chain G
148–182(35 aa)
Chain H
148–182(35 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.94 Å |
| 9JSX G175S PMEL CAF amyloid - in vitro polymerized Deposited 2024-10-01 | Parsed fields agree | Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
149–182(34 aa)
Chain B
149–182(34 aa)
Chain C
149–182(34 aa)
Chain D
149–182(34 aa)
Chain E
149–182(34 aa)
Chain F
149–182(34 aa)
Chain G
149–182(34 aa)
Chain H
149–182(34 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å |
| 9LIP The cryo-EM structure of the native PMEL fibril lamella Deposited 2025-01-14 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 48 PDB declaration: 48-meric |
Chain A
66–89(24 aa)
Chain B
148–222(75 aa)
Chain C
231–298(68 aa)
Chain D
475–491(17 aa)
Chain E
66–89(24 aa)
Chain F
148–222(75 aa)
Chain G
231–298(68 aa)
Chain H
475–491(17 aa)
Chain I
66–89(24 aa)
Chain J
148–222(75 aa)
Chain K
231–298(68 aa)
Chain L
475–491(17 aa)
Chain M
66–89(24 aa)
Chain N
148–222(75 aa)
Chain O
231–298(68 aa)
Chain P
475–491(17 aa)
Chain Q
66–89(24 aa)
Chain R
148–222(75 aa)
Chain S
231–298(68 aa)
Chain T
475–491(17 aa)
Chain U
66–89(24 aa)
Chain V
148–222(75 aa)
Chain W
231–298(68 aa)
Chain X
475–491(17 aa)
Chain Y
66–89(24 aa)
Chain Z
148–222(75 aa)
Chain a
231–298(68 aa)
Chain b
475–491(17 aa)
Chain c
66–89(24 aa)
Chain d
148–222(75 aa)
Chain e
231–298(68 aa)
Chain f
475–491(17 aa)
Chain g
66–89(24 aa)
Chain h
148–222(75 aa)
Chain i
231–298(68 aa)
Chain j
475–491(17 aa)
Chain k
66–89(24 aa)
Chain l
148–222(75 aa)
Chain m
231–298(68 aa)
Chain n
475–491(17 aa)
Chain o
66–89(24 aa)
Chain p
148–222(75 aa)
Chain q
231–298(68 aa)
Chain r
475–491(17 aa)
Chain s
66–89(24 aa)
Chain t
148–222(75 aa)
Chain u
231–298(68 aa)
Chain v
475–491(17 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.48 Å |
15 other PDB entries and 18 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | PMEL_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–34; UniProt 149–182 Author chain B; PDBConstruct 1–34; UniProt 149–182 Author chain C; PDBConstruct 1–34; UniProt 149–182 Author chain D; PDBConstruct 1–34; UniProt 149–182 Author chain E; PDBConstruct 1–34; UniProt 149–182 Author chain F; PDBConstruct 1–34; UniProt 149–182 Author chain G; PDBConstruct 1–34; UniProt 149–182 Author chain H; PDBConstruct 1–34; UniProt 149–182 |